Medicine and Dentistry
Melanoma
100%
MEK Inhibitor
38%
Immune Checkpoint Inhibitor
23%
Neoplasm
15%
Mitogen-Activated Protein Kinase
15%
Diseases
15%
Metastatic Carcinoma
7%
Targeted Therapy
7%
Discoidin Domain Receptor 1
7%
Drug Delivery System
7%
Malignant Neoplasm
7%
Combination Drug
7%
Immunotherapy
7%
Immunity
7%
Biochemistry, Genetics and Molecular Biology
MEK Inhibitor
100%
Immune Checkpoints
60%
Mitogen-Activated Protein Kinase
40%
Drug Targeting
20%
Immunity
20%
Pharmacology, Toxicology and Pharmaceutical Science
Melanoma
100%
Mitogen Activated Protein Kinase Kinase Inhibitor
38%
Immune Checkpoint Inhibitor
23%
Neoplasm
15%
Diseases
15%
Malignant Neoplasm
7%
Discoidin Domain Receptor 1
7%
Immunotherapy
7%
Combination Drug
7%
Drug Delivery System
7%